Michael Gelband’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Michael Gelband’s Portfolio PTVE Stock Details PTVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-14,428	Closed	-$166K	–	2174
2024 Q3	$166K	Buy	+14,428	New	+$166K	﹤0.01%	1475
2024 Q1	–	Sell	-19,556	Closed	-$268K	–	2054
2023 Q4	$268K	Buy	+19,556	New	+$206K	﹤0.01%	1211
2023 Q3	–	Sell	-20,966	Closed	-$159K	–	2239
2023 Q2	$159K	Buy	+20,966	New	+$160K	﹤0.01%	1709
2022 Q4	–	Sell	-12,643	Closed	-$110K	–	2234
2022 Q3	$110K	Sell	12,643 -2,977	-19%	-$30.9K	﹤0.01%	1734
2022 Q2	$156K	Buy	+15,620	New	+$157K	﹤0.01%	1695
2021 Q2	–	Sell	-24,935	Closed	-$343K	–	2904
2021 Q1	$343K	Buy	+24,935	New	+$387K	0.01%	1584
2020 Q4	–	Sell	-260,082	Closed	-$3.3M	–	2468
2020 Q3	$3.3M	Buy	+260,082	New	+$3.26M	0.07%	259

Other funds holding PTVE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Michael Gelband's PTVE Position: Q4 2024 in Review

Michael Gelband sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q4 2024, closing a stake of 14,428 shares — an estimated $166K sold.

Michael Gelband first reported a position in PTVE in Q3 2020 and held it in 7 quarters. The position peaked at $3.3M in Q3 2020. 161 funds tracked by Wall St. Rank hold PTVE as of Q4 2024.

Michael Gelband reported no remaining Pactiv Evergreen Inc. Common stock position as of Q4 2024 after selling out during the quarter.
Michael Gelband sold 14,428 Pactiv Evergreen Inc. Common stock shares in Q4 2024, an estimated $166K.
Michael Gelband first reported a position in Pactiv Evergreen Inc. Common stock in Q3 2020 and held it in 7 quarters.
Michael Gelband's Pactiv Evergreen Inc. Common stock position peaked at $3.3M in Q3 2020.
161 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q4 2024.

Based on ExodusPoint Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.